Iran and the United States have reached a tentative agreement to turn the existing ceasefire into a more long-lasting ...

Iran and the United States appeared to be negotiating on a deal to end the war, but talks could take days. In the meantime, ...

Every pill that reaches a patient’s hand, every carton of milk on a grocery shelf, every vaccine vial shipped across borders — ...

After weathering years of industry skepticism and navigating a shifting regulatory landscape, Prometheum executed its first ...

You’ve heard of the popular glucagon-like peptide-1 (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound). Now there’s a new kid on the weight ...

Ministers prone to grandstanding will have to be extra careful with what they say in the National Assembly, now that the Executive Undertakings and Petitions Committee is being revived, and will be ...

President Donald Trump's job approval rating has been underwater for more than a year, and a Pew Research Center poll shows views of his personal traits have been dropping as well. The Pew poll of ...

Zineb Riboua is a fellow at the Hudson Institute. Vladimir Putin’s ambitions are dying in Africa. As jihadists swept through Mali late last month, they also swept aside the assurances that Moscow had ...

Tesla (TSLA) is drowning in broken robotaxi promises while Wall Street ignores that margins are collapsing on aging models. BYD (BYDDY) is already dominating the affordable EV market across Asia and ...